Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1635 watching

Investor Insights

Jun 6, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.

Consensus

Hold

Valuation

Fair Value

Similar

GWO

DON'T BUY

Doesn’t own their equities but does own their bonds. Not his favourite name. Quite a valuation discount compared to other Cdn lifecos. Management track record is not as good as others so valuation difference is warranted.

BUY

Doesn’t expect they will raise dividends, as they are worried about battening down the hatches. Were very exposed to the equity and bond markets but are less vulnerable now. They are hoping for a 32% ROE. Great assets in Asia, which will be their growth profile. Mid $20’s in the next year or two would be appropriate.

HOLD

Has recovered off the bottom quite nicely. They are definitely de-risking their business. Have to get back to operating their core operations of insurance and wealth management. Will get a higher multiple with more stable earnings. Good long-term hold.

BUY

Benefiting from 3 things. 1) as bond yields go up insurance companies make more money 2) took a huge hit from their stock market exposure and as the market goes up they can unwind those losses and 3) their life insurance business continues to grow in Asia.

WAIT

Resistance at mid ’09 level, which we are almost at. He would rather pay more and have it break above.

BUY

With the stock market and bond yields going up, the stock price is going up. In terms of valuation, if you take out their Asian life insurance business, you get the North American business for free. Looks like it is recovering and you get a 2.7% yield while you wait.

SELL

Because of the derivatives they’ve created, it is highly leveraged to the stock market. If the market heads down this will have extra leverage to the downside. If you own, consider taking profits now.

COMMENT

Reporting Feb 14th. Stock has had a good bounce. Did a big acquisition in the US. Got really clobbered when they tied their success to equity markets but have now hedged. The question now is have they hedged away the rebound. It’ll take another couple of quarters to know. (Prefers Great West (GWO-T) through Power Financial (PWF-T).)

WAIT

Drop in later half of year was quite dramatic. The recovery is quite good now. Growth in Asia will add to bottom line. Things are stabilizing. There is a wait and see attitude. Get out below $17, could go up a dollar from here to $19.

HOLD

Was stopped out of this some time ago and has not got back in. Currently doing a $5 billion hedging program. Neutral on this but not interested in owning it here.

COMMENT

A warrant on the stock market. Has been moving heaven and earth to get over the annuity product risk. Have sterilized about 60% but it still leaves 40% so stock and earnings forecasts rip up and down with the stock. Probably twice as volatile as the market itself. Could give you 10%-15% more but bear in mind what you are holding.

DON'T BUY

First class insurance company in spite of their health care division in the US. Also expanding into the far east. Annoyed that there are 2 jobs in analyzing them. 1st is the basic industry and 2nd what the market’s going to do to impact the company.

BUY

Thinks this will finally be the year for the rebound of the stock. Expecting about $2 a share. Believes it’s trading under Book Value. Asian division is growing at an extremely high rate.

DON'T BUY

Not a fan of this company. Was a leveraged bet on the US stock market but has recently become a bet on US interest rates. Life insurance companies do better when interest rates are high so this stock has moved up in tandem. Believes interest rates are vulnerable.

DON'T BUY

He is not a big investor in turnaround situations. MFC, for all the good pieces of their business has been going through difficulty in some of their other businesses. You are less likely to have significant growth in the business. We have to see how this turnaround goes.

Showing 1,336 to 1,350 of 2,279 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)